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Abstract
Background: Neurovascular unit restoration is crucial for nerve regeneration, especially in critical gaps of injured
peripheral nerve. Multipotent vascular stem cells (MVSCs) harvested from an adult blood vessel are involved in
vascular remodeling; however, the therapeutic benefit for nerve regeneration is not clear.
Methods: MVSCs were isolated from rats expressing green fluorescence protein (GFP), expanded, mixed with
Matrigel matrix, and loaded into the nerve conduits. A nerve autograft or a nerve conduit (with acellular matrigel or
MVSCs in matrigel) was used to bridge a transected sciatic nerve (10-mm critical gap) in rats. The functional motor
recovery and cell fate in the regenerated nerve were investigated to understand the therapeutic benefit.
Results: MVSCs expressed markers such as Sox 17 and Sox10 and could differentiate into neural cells in vitro. One
month following MVSC transplantation, the compound muscle action potential (CMAP) significantly increased as
compared to the acellular group. MVSCs facilitated the recruitment of Schwann cell to regenerated axons. The
transplanted cells, traced by GFP, differentiated into perineurial cells around the bundles of regenerated myelinated
axons. In addition, MVSCs enhanced tight junction formation as a part of the blood-nerve barrier (BNB).
Furthermore, MVSCs differentiated into perivascular cells and enhanced microvessel formation within regenerated
neurovascular bundles.
Conclusions: In rats with peripheral nerve injuries, the transplantation of MVSCs into the nerve conduits improved
the recovery of neuromuscular function; MVSCs differentiated into perineural cells and perivascular cells and
enhanced the formation of tight junctions in perineural BNB. This study demonstrates the in vivo therapeutic
benefit of adult MVSCs for peripheral nerve regeneration and provides insight into the role of MVSCs in BNB
regeneration.
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Background
Twenty million Americans suffer from peripheral nerve
injury, which results in approximately $150 billion
healthcare expenses annually in the USA [1]. Currently,
the gold standard for traumatic peripheral nerve injuries
is doing surgery that directly repairs the discontinuity or
bridges the gap with a nerve graft or a conduit. Despite
the regenerative potential of injured peripheral neurons
(~ 1mm/day) [2], the recoveries are unpredictable with
unsatisfactory functional outcomes [3], especially in the
conduit across critical nerve gap (larger than 10 mm).
Stem cell therapy is a promising approach to promote
neural tissue regeneration. To optimize in vivo the
therapeutic effect, the appropriate source and differenti-
ation stage of transplanted stem cells are crucial [4].
Several types of stem cells have been explored for per-
ipheral nerve regeneration (PNR), including umbilical
cord blood stem cells, bone marrow-derived stem cells,
adipose-derived stem cells, and neural stem cells [5].
These adult stem cells have demonstrated promising
therapeutic benefits with less concerns about ethics,
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regulation, and tumor formation, as compared to embry-
onic stem cells. However, the underlying mechanisms
related to paracrine effect or the differentiation of trans-
planted cells into neurogenic or angiogenetic cells are
still not well understood.
Our previous work identified a new type of adult stem
cells, multipotent vascular stem cells (MVSCs) [6], from
the blood vessel wall. MVSCs have a self-renewal ability
and express markers of neural crest stem cells (NCSCs)
such as Sox10 and Sox17. These MVSCs can be differen-
tiated into neural cells and mesenchymal cells in vitro.
In vivo investigation has shown that MVSCs can be acti-
vated by vascular injuries, become proliferative, and dif-
ferentiate into smooth muscle cells (SMCs).
We postulated that MVSCs may benefit PNR by differ-
entiating into neural and/or vascular cell types in the re-
generated nerve. In this study, we transplanted MVSCs
into the nerve conduits in a critical nerve gap injury
model. In vivo therapeutic effects, including functional
recovery and cell fate, were investigated.
Materials and methods
Cell isolation and characterization
MVSCs were isolated from the tunica media layers of
the aorta of transgenic Sprague-Dawley (SD) rats ex-
pressing enhanced green fluorescence protein (GFP)
(University of Missouri, Columbia). The cell isolation
methods were described previously, using a tissue ex-
plant culture method [7]. Briefly, the tissue segments
were washed three times with phosphate-buffed saline
(PBS) supplemented with 1% penicillin/streptomycin (P/
S). The surrounding connective tissues and adventitia
were removed under a dissecting microscope. The endo-
thelium was removed by scraping off the cell layer on
the luminal surface with sterile scalpel blades. Using a
tissue explant culture method, the tunica media was cut
into millimeter size and placed onto the surface coated
with 1% CellStart (Invitrogen) in 6-well plates. The cells
were initially cultured in DMEM with 2% chick embryo
extract (MP Biomedical), 1% fetal bovine serum, 1% N2
(Invitrogen), 2% B27 (Invitrogen), 100 nM retinoic acid
(Sigma-Aldrich), 50 nM 2-mercaptoethanol (Sigma-Al-
drich), 1% P/S, and 20 ng/ml bFGF (R&D Systems) (as
phenotype maintenance medium). Cells were then
seeded onto CellStart-coated dishes and maintained at
37 °C in an incubator with 5% CO2. Among all isolated
cells, small population of cells (less than 10%) were
small, round, and negative for smooth muscle myosin
heavy chain (SM-MHC) expression, a mature marker of
vascular SMCs [8]. These SM-MHC− cells, mostly
MVSCs [6], were expandable with enhanced telomerase
activity as compared to SM-MHC+ cells.
For immunostaining, cells were fixed with 4% parafor-
maldehyde (PFA), permeabilized with 0.5% Triton-100
(Sigma-Aldrich), and blocked with 1% bovine serum
albumin (Sigma-Aldrich). For the staining of cell
markers, samples were incubated with specific primary
antibodies: Sox10 (ab155279, Abcam), Sox17 (ab84990,
Abcam), Ki67 (ab197234, Abcam), smooth muscle α-
actin ( -SMA) (ab5694, Abcam), calponin-1 (CNN1)
(ab233854, Abcam), CD31 (ab28364, Abcam), peripherin
(ab4666, Abcam) or S100β (ab4066, Abcam) for 2 h at
room temperature, washed with PBS for 3 times, and
then incubated with appropriate Alexa 488- and/or
Alexa 546-labeled secondary antibodies (Molecular
Probes). The nuclei were stained with 4,6-diamidino-2-
phenylindole (DAPI) (Invitrogen). Fluorescence images
were collected using a Zeiss LSM710 confocal
microscope.
Nerve conduit fabrication
Electrospinning technique was used to produce nanofi-
brous nerve conduits as previously described [4]. Non-
woven aligned nanofibrous nerve conduits composed of
poly(L-lactide-co-caprolactone) (PLCL) (70:30, Purac
Biomaterials), poly(propylene glycol) (Acros Organics),
and sodium acetate (Sigma) were fabricated by using a
customized electrospinning process. To make tubular
scaffolds with aligned nanofibers in the longitudinal dir-
ection on the luminal surface, a rotating mandrel assem-
bly with two electrically conductive ends and a central
non-conductive section was used. The jet stream of
polymer solution from the spinneret whipped between
the two conductive ends, resulting in longitudinally
aligned nanofibers, forming a tubular scaffold on the
non-conductive portion of the mandrel. To enhance the
mechanical strength of the scaffolds, the outer layers of
random nanofibers were deposited onto this inner layer
of longitudinally aligned fibers [9].
Matrigel matrix formulation and preparation of tissue
engineered conduits
The Matrigel we used in this study was Growth Factor
Reduced (GFR) BD Matrigel Matrix (Cat. No.356230).
The PLCL conduits were cut to 1.1cm-long and steril-
ized with ethylene oxide gas before use. MVSCs were
detached and re-suspended in serum-free MVSC main-
tenance medium to the density of 40 million cells/ml,
modified from previous protocol [10]. The cell suspen-
sion was then mixed with cold GFR matrigel solution at
1:1 ratio (volume to volume). Cells in 25 μL of matrigel
was used to fill up one 1.1-cm PLCL conduit and thus
the transplanted cell number was 1 million per conduit.
The filled conduits were incubated in 37°C for 1 h to
allow matrigel solidification. Serum-free MVSC main-
tenance medium was then added to cover the tissue-
engineered nerve conduits for overnight culture in 37°C
incubator before surgery.
Huang et al. Stem Cell Research & Therapy          (2019) 10:234 Page 2 of 9
In vivo transplantation of stem cells and nerve conduits
To investigate the in vivo therapeutic effect, 18 adult SD
rats were randomly divided into three treatment groups
(acellular, MVSC, and autograft, N = 6 in each group).
MVSC transplantation was performed using allogenic
cells which were isolated from GFP rats. All animal ex-
perimental procedures were approved by the Animal
Care and Use Committee at UC Berkeley and were car-
ried out according to the institutional guidelines. Adult
female SD rats (Charles River) weighing 200–250 g were
used in all treatment groups. For nerve conduit implant-
ation, an incision was made over the skin above the hip
joint with a sterile scalpel. Under a surgical microscope,
the sciatic nerve was isolated and severed with a micro-
scissor at two spots to make a 10-mm gap. Then, the tis-
sue-engineered nerve conduits (11 mm in length, 1.5
mm in inner diameter), with or without MVSCs, were
inserted between the two nerve stumps and then sutured
with 9-0 nylon monofilament sutures (Ethilon, Ethicon).
The overlying muscle layers and skin were sutured with
4-0 absorbable sutures (polydioxanone, Ethicon) to close
the surgery site. For the autograft group, 10-mm
segment of sciatic nerve was transected and micro-
scopically repaired in a reverse fashion. After 1-month
transplantation, nerve regeneration was assessed by
electrophysiology. To confirm the histologic evidence,
all animals were euthanized and the conduits were
harvested, fixed in 4% PFA for immunohistochemistry
(IHC) analysis.
Electrophysiology
Electrophysiology testing was performed to evaluate the
functional recovery of regenerated nerve by following
the previous method [4]. In brief, the rat sciatic nerve
was exposed, and electrical stimuli (single-pulse shocks,
1 mA, 0.1 ms) were applied to the native sciatic nerve
trunk at the point 5 mm proximal to the graft suturing
point. Amplitude of the depolarization was recorded as
compound muscle action potential (CMAP) on the
gastrocnemius belly from 1 to 12 V or until a supramaximal
CMAP was reached. Normal CMAP from the unoperated
contralateral side of the sciatic nerve was also recorded for
comparison, at the same level of the sciatic nerve. Grass
Tech S88X Stimulator (Astro-Med Inc.) was used for the
test, and PolyVIWE16 data acquisition software (Astro-
Med, Inc.) was used for recording. Recovery rate is the ratio
of injured hindlimb’s CMAP to contralateral normal hin-
dlimb’s CMAP of a rat [4]. After electrophysiological evalu-
ation, the rats were sacrificed to harvest the regenerated
nerve for histological examination.
Fig. 1 In vitro characterization and differentiation of MVSCs isolated from rat aorta. a MVSCs were isolated from the aorta of GFP rats by using a
tissue explant culture method, expanded, and stained for Sox10, Sox17, and Ki67. b MVSCs were stained for vascular cell markers α-SMA, CNN1,
and CD31. c MVSCs were differentiated into peripheral neurons (Peripherin+) and Schwann cells (S100β+) in vitro. Red color indicates positive
staining for individual marker; blue color indicates positive DAPI staining. Scale bar, 50 μm
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IHC analysis
The nerve conduits were harvested and fixed in 4% PFA
at 4 °C for 2 h. After being washed with PBS, the tissues
were cryoprotected with 30% sucrose in PBS at 4 °C
overnight, and were then embedded in optimum cutting
temperature compound, followed by being frozen at −
80 °C. The frozen samples were cryosectioned longitu-
dinally and transversely at − 20 °C for the thickness of
10 μm. The slices were placed onto Superfrost plus slides
and stored at − 20 °C. IHC staining was performed for
histological analysis. The slices were permeabilized with
0.5% Triton X-100 in PBS for 30 min, blocked with 4%
normal goat serum in PBS for 1 h, and then incubated
overnight at 4 °C with primary antibodies. The slides
were then washed with PBS and incubated with second-
ary antibodies for 1 h at room temperature. After further
PBS washing, the coverslips were mounted and viewed
with a fluorescent microscope (Zeiss). The primary anti-
bodies used for IHC analysis in this study were as
follows: neural filament-medium polypeptide (NFM)
(ab7794, Abcam), S100β (ab4066, Abcam), Claudin-1
(ab15098, Abcam), CD31 (ab28364, Abcam), -SMA
A
B
D
C
Fig. 2 In vivo evaluation of functional recovery. a Schematic showing that GFP+ MVSCs (allograft) were mixed with Matrigel matrix and injected
into a PLCL nerve conduit that was used to bridge a critical gap of injured nerve in Sprague-Dawley rats. b Recordable amplitude of
electrophysiological depolarization in each rat following 1-month recovery. c CMAP of the sciatic nerve was measured following 1-month
recovery. Recovery rate is the ratio of injured hindlimb’s CMAP to contralateral normal hindlimb’s CMAP of a rat. For CMAP recovery, the acellular
group and MVSC-engrafted group showed a significant difference (*p < 0.05). Bars represent mean ± standard error. d Representative curves of
CMAP (rat #1 of each group) are shown for the acellular group, the MVSC-engrafted group, and the autograft group
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(ab5694, Abcam), and CNN1 (ab233854, Abcam). Fluor-
escence-tagged anti-mouse and anti-rabbit secondary
antibodies (Abcam) were used.
Statistical analysis
The data was reported as mean ± standard error of
mean, unless otherwise described. Comparisons among
values for groups greater than two were performed by
one-way analysis of variance, and differences between
the groups were then determined using a Tukey’s post
hoc test. For all experiments, a value of p < 0.05 was
considered statistically significant. GraphPad Prism soft-
ware (version 8.0) was used for all statistical analyses.
Results
Characterization of MVSCs isolated from rat aorta
In vitro characterization of SM-MHC− cells revealed
positive expression of stem cell markers Sox10 and
Sox17, and these cells were highly proliferative (Ki67
staining) and expandable (Fig. 1a). MVSCs were negative
for -SMA and CNN1 and distinguishable from
vascular SMCs; in addition, MVSCs were negative in
CD31 expression, indicating a non-endothelial origin
(Fig. 1b). After an in vitro induction, MVSCs differenti-
ated into the neural lineage, such as peripheral neuron
(peripherin+) and Schwann cell (S100β+) (Fig. 1c).
MVSCs promoted in vivo functional recovery in critical
nerve gap injuries
Adult SD rats were randomly divided into three treat-
ment groups (acellular, MVSC, and autograft), in order
to compare the therapeutic benefits. HA-collagen gel
with MMP-targeting crosslinker was used for cell deliv-
ery into the nerve conduits. Hydrogel only (acellular) or
MVSCs in hydrogel were injected into 10-mm PLCL
nanofibrous electrospun conduit to bridge the critical
sciatic nerve gap in the left hindlimb (Fig. 2a). For the
autograft group, the 10-mm transected sciatic nerve was
reversed (proximal vs. distal) and sutured back in situ.
The functional recovery of the regenerated nerve was
evaluated by electrophysiology testing. CMAP of the in-
jured sciatic nerve and the contralateral intact nerve
Fig. 3 MVSCs formed perineurium-like structure in the regenerated nerve. IHC analysis of cross-sections in the middle of the nerve conduits was
performed after 2-month transplantation. The samples were stained for NFM (axons), S100β (Schwann cell), and Claudin-1 (tight junction). Red
color indicates positive staining for individual marker; blue color indicates positive DAPI staining; green color indicates GFP+ MVSC-derived cells.
Right column: magnified images (scale bars: 100 μm in the left column, 50 μm in the right column)
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were measured and compared. One month after surgery,
the MVSCs and autograft groups consistently showed a
higher rate of detectable CMAP (Fig. 2b, c). For the rats
with detectable CMAP, the recovery rate of each rat was
calculated as a percentage of CMAP over the unin-
jured contralateral sciatic nerve. A significant differ-
ence was observed between the MVSC group and the
acellular group (p < 0.01) but not between the MVSC
group and the autograft group (Fig. 2d). The latency
period of recordable depolarization did not show a
significant difference among the three groups (data
not shown).
MVSCs formed perineural structure and tight junctions in
the regenerated nerve
Two month after nerve injury, the regenerated nerve
across the conduit was harvested for histological evalu-
ation. IHC staining revealed positive staining of NFM
(axon) and S100β (Schwann cells) across the cross-sec-
tion area, with more axons and Schwann cells near the
conduit wall (Fig. 3), suggesting that myelinated axons
regenerated more effectively near the nerve conduit sur-
face. Higher resolution analysis demonstrated that GFP+
MVSCs formed a perineurium-like structure around
bundles of axons (Fig. 3). In addition, IHC staining
showed co-localization of GFP with Claudin-1 (Fig. 3),
an important tight junction protein and a perineurium
marker [11, 12]. This result suggested that the trans-
planted MVSCs could facilitate the formation of tight
junctions in the blood-nerve barrier (BNB) within the
regenerating nerve.
Longitudinal sections of the regenerated nerve demon-
strated that disordered Schwann cell alignment was ob-
served in acellular nerve conduit, with diminished
myelination (S100β) at distal regenerated nerve (Fig. 4).
In contrast, the MVSC-transplanted group demonstrated
well-aligned S100β+ cells with GFP+ staining in the en-
tire length of the conduit, implying that MVSCs could
facilitate the recruitment of Schwann cells and play a
supporting role in axon growth.
MVSCs enhanced angiogenesis and differentiated into
perivascular cells within regenerated nerve
To further investigate the functionality of transplanted
MVSCs, we performed IHC analysis of vascular markers.
CD31 (endothelial marker) staining showed more
Fig. 4 Longitudinal analysis of the regenerated nerve after 1-month transplantation. Longitudinal sections showed the distribution of Schwann
cells (S100β+) and GFP+ MVSCs in the proximal, middle, and distal segments of the nerve conduits. Red color indicates positive staining for S100β;
blue color indicates positive DAPI staining; green color indicates GFP+ cells. Scale bar, 100 μm
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microvessels in the MVSC-transplanted group (Fig. 5).
In addition, the number of -SMA+ and CNN1+ cells
also significantly increased in the MVSC-treated group.
Close examination of the regenerated nerve in the
MVSC-transplanted group demonstrated CD31+ tubular
structure throughout the cross-section of the regener-
ated nerve, which was surrounded by GFP+ MVSCs
(Fig. 6). Co-localization of GFP+ MVSCs and -SMA+
tubular structure was observed, indicating that the
MVSCs differentiated into perivascular cells of microves-
sels. In addition, CNN1 is an intermediate marker of
SMCs and a regulatory protein involved in SMC con-
tractility [13, 14]. Co-localization of GFP+/CNN1+ signal
further implied that MVSC could differentiate into peri-
vascular cells to stabilize the microvessels in the regener-
ated nerve.
Discussion
Regeneration of the peripheral nerve across a critical gap
remains a great challenge and unsolved problem for
decades. Appropriate stem cell therapy still holds the
holy grail to promote regeneration by differentiating into
neuron and/or glial cells or supporting endogenous
neurogenesis with paracrine effect. Pericytes are believed
to function as progenitor cells with great potential for
regenerative medicine [15], including neural cell differ-
entiation and regeneration [16, 17]. However, the current
view toward endogenous pericytes as multipotent tissue-
resident progenitors is still under debate [18]. MVSCs
express NCSC markers and can be expanded rapidly in
culture and differentiated into neural lineage cells along
with SMCs, which clearly distinguishes MVSCs from
other known progenitor cells, making it unique for the
regeneration of neurovascular structures. In this study,
the neurogenic potential of MVSCs was verified by the
expression of NCSC markers (Sox10+, Sox17+) and the
differentiation into glial cells (S100β+) and peripheral
neurons (peripherin+). Implantation of MVSCs into crit-
ical nerve gap enhanced the functional recovery, demon-
strating in vivo therapeutic potential.
Fig. 5 Microvessel formation in the regenerated nerve. IHC staining of CD31, α-SMA, and CNN1 for the comparison of microvessel formation at
the middle segments of the regenerated nerve in acellular conduits and MVSC-transplanted conduits at 2-month post-transplantation. Red color
indicates positive staining for individual marker; blue color indicates positive DAPI staining. Scale bars, 100 μm
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Microvessels in the peripheral nerve are critical to sup-
port cell survival and regeneration. In this study, trans-
planted MVSCs enhanced newly formed microvessels in
the regenerated nerve, as compared to the acellular group.
Cell fate analysis further revealed that the transplanted
MVSCs differentiated into perivascular cells ( -SMA+/
CNN1+). Hence, these transplanted MVSCs may support
and stabilize the newly formed microvessels.
Regenerated microvessels across the nerve gap can act
as a scaffold to guide Schwann cells for efficient adhesion
and migration, leading to enhanced axon growth and
myelination [19]. Interestingly, MVSC transplantation in-
creased the recruitment of Schwann cells, showing strik-
ing difference near the distal end of the nerve conduits. It
is possible that MVSCs enhance microvessel formation,
which in turn facilitates the directional migration of
Schwann cells toward the distal end. Alternatively, MVSCs
may help recruit Schwann cells via paracrine signaling to
enhance axon myelination. Although MVSCs have poten-
tial to differentiate into Schwann cells or peripheral neu-
rons in vitro, we did not detect MVSC differentiation into
neural lineages in vivo, suggesting that MVSCs tend to dif-
ferentiate into mesenchymal lineages in the regenerating
nerve. These findings underscore the difference between
adult MVSCs and NCSCs derived from induced pluripo-
tent stem cells. As shown in our previous work, NCSCs in
nerve conduits differentiated into Schwann cells to en-
hance the myelination of axons [9].
The transplanted MVSCs in the nerve conduits
formed a perineural structure, wrapping around the
regenerated axon bundles. We further demonstrated
that transplanted MVSCs co-localized with claudin-1+
cells, suggesting the formation of tight junction in BNB
[20]. BNB protects peripheral nerves from immunologic
attacks and helps to maintain the stability of the endo-
neurial-endothelial interface [21]. As far as we know,
this is the first demonstration that the transplantation
of adult stem cells facilitates BNB formation in PNR.
This effect may be attributed to the differentiation of
MVSCs into perivascular cells to stabilize the microves-
sels, or to the formation of a perineurium-like structure
by MVSCs, which warrants further investigation.
Fig. 6 MVSCs differentiated into perivascular cells in regenerating nerve tissue. IHC analysis of the middle segment of the MVSC-transplanted
conduits at 2-month post-transplantation was performed by staining for endothelial cell marker (CD31) and perivascular cell markers (α-SMA and
CNN1). MVSCs were labeled by GFP. Red color indicates positive staining for individual marker; blue color indicates positive DAPI staining; green
color indicates GFP+ cells (scale bars: 100 μm in the left column, 10 μm in the right column)
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Conclusions
In summary, this study demonstrates the novel functions
of transplanted MVSCs in promoting PNR, including
Schwann cell recruitment, differentiation into perineural
and perivascular cells, and tight junction formation in
BNB. These findings provide insight into the interactions
of neural cells and vascular cells in regenerating neuro-
vascular bundles and give rise to new strategies for nerve
regeneration.
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